← Back to Patent Explorer
US4592998A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for coupling biological substances by covalent bonds

Assignee: Institut Pasteur
•
Filing: 1983-12-15
•
Granted: 1986-06-03
•
Expires: 2003-12-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This process involves the use of benzoquinone as cross-linking agent in large excess compared with the substance to be activated. The activation reaction is realized in a homogeneous liquid medium. Said process making it possible for example to couple antibodies to enzymes for determining or detecting said antibodies. The process can be used for the determination of antitetanic antibodies in human serum.

Inventors

  • 👤 Stratis Avrameas
  • 👤 Therese M. F. Ternynck

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 03:28
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/531; G01N33/532; G01N2474/00; G01N2474/20; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S530/00; Y10S530/866

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 136 words
In a process for coupling at least two substances by covalent bonds by means of a cross-linking agent, said cross-linking agent being benzoquinone, the improvement comprising the steps of (a) mixing a first substance dissolved in solution with at least about 200 times its molar amount of benzoquinone, this reaction known as the activation reaction being performed in a homogeneous liquid medium, said first substance being selected from the group consisting of proteins, glycoproteins other than Fab fragments of immunoglobulins, polysaccharides and nucleic acids (b) removal of the reaction products of step (a) and the excess benzoquinone and recovery of the activated first substance; (c) contacting the activated first substance with the second substance to be coupled, said second substance being selected from the group consisting of proteins, glycoproteins, polysaccharides, nucleic acids and red blood cells.
Claim 2
Dependent Claim 136 words
In a process for coupling at least two substances by covalent bonds by means of a cross-linking agent, said cross-linking agent being benzoquinone, the improvement comprising the steps of (a) mixing a first substance dissolved in solution with at least about 200 times its molar amount of benzoquinone, this reaction known as the activation reaction being performed in a homogeneous liquid medium, said first substance being selected from the group consisting of proteins, glycoproteins other than Fab fragments of immunoglobulins, polysaccharides and nucleic acids (b) removal of the reaction products of step (a) and the excess benzoquinone and recovery of the activated first substance; (c) contacting the activated first substance with the second substance to be coupled, said second substance being selected from the group consisting of proteins, glycoproteins, polysaccharides, nucleic acids and red blood cells.
Claim 3
Dependent Claim 46 words
A process according to claim 1, wherein the activation reaction with benzoquinone is effected at a temperature not higher than 22° C. for from a few minutes to 24 hours, until the coupling agent is attached to the substrate to be activated, which is a protein.
Claim 4
Dependent Claim 44 words
A process according to claim 1, wherein during the benzoquinone reaction an excess of the coupling agent is used compared with the first substance to be activated, and the molar ratio of benzoquinone first substance to be activated is up to 1000 to 1.
Claim 5
Dependent Claim 36 words
A process according to claim 1, wherein step (b) for the removal of reaction products and excess benzoquinone is effected by passing the substances through an exchange resin in the form of a molecular filtration column.
Claim 6
Dependent Claim 75 words
A process according to claim 1, wherein step (c) for coupling the substance activated after reaction with benzoquinone and the other substance, is carried out at room temperature for a time in the range of from 1 to 48 hours in a buffered aqueous medium with an excess of the activated first substance based on the second substance to be coupled until the second substance to be coupled is attached to the activated first substance.
Claim 7
Dependent Claim 32 words
A process according to claim 1, wherein during step (c) of the process an excess of the first activated substance or of the second activated substance is used, based on the other.
Claim 8
Dependent Claim 12 words
A process according to claim 1, wherein the activation agent is parabenzoquinone.
Claim 9
Dependent Claim 25 words
A process according to claim 1, wherein the first substance is a material selected from the group consisting of peroxidase, alkaline phosphatase and glucose oxidase.
Claim 10
Dependent Claim 31 words
A process according to claim 1, wherein the said second substance is a materal selected from the group consisting of a protein antibody, antigen, red blood cells, nucleic acids and polysaccharides.
Claim 11
Dependent Claim 23 words
A process according to claim 1, wherein the first substance is selected from the group consisting of antibodies, antigens, nucleic acids and polysaccharides.
Claim 12
Dependent Claim 34 words
A process according to claim 1, wherein the second substance is selected from the group consisting of peroxidase, alkaline phosphatase, glucose oxidase, β-galactosidase, lactoperoxidase, antibody, and Fab fragments of antibodies to enzymes and virus.
Claim 13
Dependent Claim 16 words
A process according to claim 1, wherein the first substance is tetanus antigen in human serum.
Claim 14
Dependent Claim 17 words
A process according to claim 1 wherein said second substance is an antibody to a red cell.
Claim 15
Dependent Claim 21 words
A process according to claim 1, wherein the first substance is peroxidase and the second substance is a red blood cell.
Claim 16
Dependent Claim 41 words
A process according to claim 1, wherein the activation treatment of step (a) is effected by contacting the first substance which is a protein dissolved in a buffered aqueous medium, with benzoquinone in solution said solution being a lower aliphatic alcohol.
Claim 17
Dependent Claim 26 words
A process according to claim 15, wherein the pH of the buffered aqueous reaction medium is in the range of from about 5.5 to about 9.
Claim 18
Dependent Claim 109 words
A process for determining the presence of antibody or antigen in a biological fluid comprising the steps of (a) mixing a biological fluid dissolved in solution with at least 200 times the molar amount of benzoquinone based on the amount of antibody or antigen in the fluid, said fluid containing a first substance comprising antibodies or antigens, (b) removing the product of step (a) and the excess benzoquinone and recovering the activated first substance, (c) contacting the activated first substance with red blood cells, and (d) assaying the product of step (c) by hemagglutination or hemolysis as an index of the antibody or antigen content of the biological fluid.
Claim 19
Dependent Claim 109 words
A process for determining the presence of antibody or antigen in a biological fluid comprising the steps of (a) mixing a biological fluid dissolved in solution with at least 200 times the molar amount of benzoquinone based on the amount of antibody or antigen in the fluid, said fluid containing a first substance comprising antibodies or antigens, (b) removing the product of step (a) and the excess benzoquinone and recovering the activated first substance, (c) contacting the activated first substance with red blood cells, and (d) assaying the product of step (c) by hemagglutination or hemolysis as an index of the antibody or antigen content of the biological fluid.

References Cited (Backward Citations)

US3322634A Cited
US4193982A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-06-02 1989-12-02 1990-06-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-06-02 1993-12-02 1994-06-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-06-02 1997-12-02 1998-06-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag